YOLFTbeta
CKH Food & Health Limited

CKH Food & Health Limited

900120 · KQ · Healthcare / Drug Manufacturers - Specialty & Generic

2,920.00KRW-15.00 (-0.51%)

Price History

Full chart

Market Stats

Previous Close2,935.00
Open2,965.00
Day Range2,900.00 – 2,970.00
52-Week Range709.00 – 3,920.00
Volume1.96K
Market Cap11.62B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.86
50-Day Avg1,075.86
200-Day Avg1,795.31

About

CXI Healthcare Technology Group Limited engages in the manufacture and distribution of health foods. It provides Chinese medicine-based health supplements in capsule, tablet, drink, and tea forms. The company was formerly known as CKH Food & Health Limited and changed its name to CXI Healthcare Technology Group Limited in October 2023. CXI Healthcare Technology Group Limited was founded in 2009 and is based in Grand Cayman, the Cayman Islands.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Jin Sheng Lin
  • Employees26
  • HeadquartersCricket Square, Grand Cayman, Cayman Islands, KYI-1103, Korea
  • Websitehttps://www.ckhfnh.co.kr

Leadership

  • Mr. Jin Sheng LinCEO & Director · b. 1963
  • Mr. Yaorong GuoDirector & Director · b. 1949
  • Mr. Jungao LyuDirector & Director · b. 1980
  • Mr. Ben Zheng LiuDirector & Director · b. 1979

Financials

Income Statement

Currency: KRW2007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-30
Total Revenue100.27M271.73M507.69M129.91B188.95B236.60B264.66B286.41B317.90B1.64B873.39M860.98M777.84M373.11M609.73M545.21M377.03M376.93M
Growth (%)-+170.99%+86.84%+25488.22%+45.45%+25.22%+11.86%+8.22%+10.99%-99.48%-46.77%-1.42%-9.66%-52.03%+63.42%-10.58%-30.85%-0.03%
Cost of Revenue26.43M71.48M148.25M39.42B73.89B98.66B126.66B135.93B151.23B855.59M561.41M865.34M814.91M440.39M482.55M392.70M228.51M214.71M
Gross Profit-------149.34B166.67B785.07M311.98M-4.37M-37.07M-67.28M127.18M152.51M148.53M162.22M
Gross Margin-------52.14%52.43%47.85%35.72%-0.51%-4.77%-18.03%20.86%27.97%39.39%43.04%
Operating Expense-------57.62B65.85B396.40M293.79M449.03M401.42M523.19M100.78M118.66M111.81M59.73M
Operating Income33.80M119.81M241.62M58.24B79.97B95.11B87.44B91.72B100.82B388.67M18.19M-453.40M-438.48M-590.47M26.40M33.86M36.72M102.49M
Operating Margin33.71%44.09%47.59%44.83%42.32%40.20%33.04%32.02%31.71%23.69%2.08%-52.66%-56.37%-158.26%4.33%6.21%9.74%27.19%
EBITDA---------------31.75B31.51B53.99B
EBITDA Margin---------------5823.02%8357.57%14323.40%
Net Income---44.01B55.88B67.87B60.50B63.61B73.45B288.86M4.69M-438.20M-424.82M-579.25M29.72M32.17M39.63M159.36M
Net Income Margin---33.88%29.58%28.68%22.86%22.21%23.11%17.61%0.54%-50.90%-54.61%-155.25%4.87%5.90%10.51%42.28%
R&D6.13M8.52M13.01M-5.10B6.53B7.95B8.60B9.50B8.73B6.21B12.87B11.80B10.86B3.82B9.32B9.75B4.94B
R&D as % of Total Revenue6.11%3.14%2.56%-2.70%2.76%3.01%3.00%2.99%532.37%710.98%1495.27%1517.14%2910.19%626.11%1708.88%2586.07%1310.43%
Interest Expense00000000000006.82M17.39M53.79M2.86M5.06M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.83%2.85%9.87%0.76%1.34%

Balance Sheet

Currency: KRW2007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-30
Total Assets232.99M397.89M440.67M211.36B251.69B407.78B483.98B485.68B625.90B3.64B3.61B3.31B2.80B2.13B2.20B2.22B2.30B483.86B-
Total Liabilities200.25M283.50M146.42M28.11B28.12B88.04B93.64B70.63B88.88B152.83M97.18M220.76M134.66M48.90M72.81M45.95M18.59M2.72B-
Total Equity32.21M111.56M291.77M183.26B223.57B319.73B390.34B415.05B537.02B3.49B3.51B3.09B2.66B2.08B2.13B2.17B2.28B481.14B-
Cash85.30M28.39M30.42M92.55B65.17B175.99B244.07B283.71B377.73B87.00K2.55B1.22B996.92M1.26B147.58M10.96K23.33K159.91B-
Total Debt--------------1.29M----

Cash Flow

Currency: KRW2007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-30
Operating Cash Flow12.17M32.56M190.12M14.03B67.93B58.93B71.46B77.93B95.51B338.77M54.28B-57.44B-58.06B-44.32B8.72B35.98B174.52M229.30M
Investing Cash Flow--------5.03B-30.80B-200.23M1.18B-168.37B19.96B88.86B-204.56B140.45M-139.74K86.71M
Financing Cash Flow57.05M71.85M-82.59B-59.75B--2.15B-1.86B-8.34M399.75M264.77M861.43M694.07M742.78M1.16B8.04M1.33M
Capital Expenditure11.36M25.10M24.76M3.88B2.58B7.61B3.47B5.88B908.48M1.61M92.82M40.93M40.93M65.70B204.89B5.78M00
Free Cash Flow--------------110.02B-196.17B35.98B31.60B43.67B
Dividends Paid----4.00B3.38B5.35B7.75M7.75M7.75M7.75M-------
FCF to OCF-------------248.23%-2248.71%99.98%18105.00%19043.00%

Earnings

Report DateSep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Feb 24, 2017Mar 31, 2017Jun 30, 2017Sep 30, 2017Feb 28, 2018May 28, 2018Jun 30, 2018Sep 30, 2018Mar 4, 2019Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Mar 2, 2021May 31, 2021Jun 30, 2021Nov 29, 2021Mar 17, 2022Jun 9, 2022Jun 30, 2022Dec 28, 2022Mar 23, 2023Jun 23, 2023Jun 30, 2023Nov 29, 2023Feb 29, 2024May 30, 2024Jun 30, 2024Nov 28, 2024Mar 4, 2025May 30, 2025Jun 30, 2025Sep 30, 2025Mar 2, 2026Mar 31, 2026
EPS Estimate---------------------------------------------------------------
EPS Actual6741.308953.536405.2911763.537970.9811148.769211.7412218.138813.559093.958428.249687.449835.959567.069752.466635.348803.099460.639525.239009.927878.636872.666123.404233.062963.1415.63846.52-4017.65-8642.97-213.73-174.18-5435.97-8018.87-155.65-8198.72-8013.60-6494.90-6580.56-6986.24-24779.51502.01-16.66-8.063074.91-10.25-2.528.512712.0715.33-40.89-5.353650.5435.02-5.769.343750.9121.70-8.24-5.001701.04787.48-128.71-445.85
Surprise---------------------------------------------------------------
Timing-------------------------Pre-market---Pre-marketPre-market--Pre-market------------Pre-market-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursPre-marketPre-market--Pre-market-

Key Statistics & Ratios

Market Cap11.62B
Enterprise Value-38.48B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.23
Price / Book0.01
Revenue (TTM)51.45B
Gross Profit (TTM)14.31B
EBITDA32.49B
Profit Margin16.82%
Operating Margin-33.32%
Return on Equity1.59%
Return on Assets0.73%
Shares Outstanding11.17M
Shares Float10.05M
Beta0.86
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20121×
7857.14Jun 28, 2012
20111×
8230.95Dec 29, 2011
20101×
12109.52Dec 29, 2010

Stock Splits

  • Jun 26, 20261:5
  • Aug 1, 20251:10
  • Jun 29, 201621:20